A Randomized, Mutlti-Center, Double Blind and Parallel Controlled Clinical Trial for Kuntai Capsules in the Treatment of Climacteric Syndromes
CHEN Rong,LIN Shou-qing,YANG Xin,LUAN Yan-qiu,CHEN Ji-ying,CHAI Li-na,ZHANG Ying,JIANG Ying
DOI: https://doi.org/10.3321/j.issn:1003-3734.2005.12.030
2005-01-01
Abstract:Objective:To evaluate the efficacy and safety of Kuntai capsules,a Chinese Traditional Medicine,in the treatment of climacteric syndrome.Methods:A randomized,double blind,multi-center and parallel control clinical study enrolled 147 menopausal women with hot flushes more than 3 times a day,who were randomly administered with either Kuntai capsules(4 capsules,tid,n=77) or estradiol valerate(E_2V) tablets(0.5 mg,qd,n=70) for 3 months.The patients were stratified according to their perimenopasual and postmenopausal stage in each arm group.The patients were requested to record their climacteric symptoms,vaginal spotting and breast tender on the daily basis,and were assessed in the improvement of climacteric symptoms using the Kupperman Menopausal Scores(KMS) at each scheduled study visit.The serum estradiol(E_2) level and vaginal epithelial maturation index were measured at the beginning and the end of the study.Results:Compared to the estradiol therapy,the Kuntai-treated patients showed no significant difference in the improvement of climacteric symptoms based on the KMS evaluation in the 3-month course of the therapy(86.2% vs.78.9%,P0.05).The hot flushes were significantly decreased in both groups(92.3% vs.96.5,P0.05).The E_2 levels and vaginal epithelial cell maturation index were significantly increased in the Kuntai group at the end of therapy,compared with the pre-therapy(P0.01 and P0.05,respectively).No serious adverse events were reported.Conclusion:Kuntai capsules provide an alternative therapy for women with climacteric symptoms,and show more efficacies for perimenopausal women than for postmenopausal women.